Assessment of the Lipid Lowering Effect of Rosuvastatin Compared to Atorvastatin in Subjects With Coronary Heart Disease
Clinical trial NCT00235950 · COMPLETED
Trial details
- NCT number
- NCT00235950
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-01-01
- Primary completion
- 2006-03-01
- Enrollment
- 255
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.